NM_000044.6(AR):c.1174C>T (p.Pro392Ser) AND Partial androgen insensitivity syndrome
- Germline classification:
- no classifications from unflagged records (1 submission)
- Last evaluated:
- Jan 25, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000196772.10
Allele description [Variation Report for NM_000044.6(AR):c.1174C>T (p.Pro392Ser)]
NM_000044.6(AR):c.1174C>T (p.Pro392Ser)
Condition(s)
- Name:
- Partial androgen insensitivity syndrome (PAIS)
- Synonyms:
- ANDROGEN INSENSITIVITY, PARTIAL, WITH OR WITHOUT BREAST CANCER; Gynecomastia, familial; Pseudohermaphroditism, Incomplete male, type I; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0010720; MedGen: C0268301; Orphanet: 90797; OMIM: 312300
-
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase isoform X2 [Homo sapiens]
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase isoform X2 [Homo sapiens]gi|1034611525|ref|XP_016858815.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Flagged submissions
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV000255325 | UCLA Clinical Genomics Center, UCLA - CES | flagged submission Reason: Outlier claim with insufficient supporting evidence Notes: None (Lee et al. (JAMA. 2014)) | Pathogenic (Jul 1, 2014) | unknown | clinical testing |
Last Updated: Oct 13, 2024